Bionano genomics announces american society of hematology (ash) annual meeting presentations featuring ogm utility across blood cancer research applications

San diego, dec. 08, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced its participation in the american society of hematology (ash) annual meeting and exposition 2022 with a broad range of content covering optical genome mapping's (ogm) utility for research areas including myeloid cancer, hematological malignancy, leukemia and blood disorders.
BNGO Ratings Summary
BNGO Quant Ranking